Kerry Group Plc · EURONEXT:KRZ
Kerry — Investor Day (October 2026)
37 slides from Kerry's investor day presentation, Oct 8, 2026
Slide 1: Kerry Investor Day 8 October 2026
Kerry Investor Day 8 October 2026
Slide 2: Disclaimer: Forward Looking Statements
Disclaimer: Forward Looking Statements This presentation may contain forward looking statements with projections regarding, among other things, Kerry’s strategy, revenues, earnings, EBITDA, EBITDA margin, finance costs, tax rate, capital expenditure, dividends, share buybacks, cash flow, net debt or
Slide 3: Edmond Scanlon, Chief Executive Officer
IKKERRY Solving for a Complex World EDMOND SCANLON Chief Executive Officer
Slide 4: Key Messages
Key Messages 1. Highly Dynamic Market – Particularly Attractive for Kerry 2. Industry’s Most Relevant Technology Portfolio & Business Model 3. Strategy Execution, Financial Delivery
Slide 5: Kerry Today
Kerry Today STRATEGIC BUSINESS DEVELOPMENT STRONG FINANCIAL PERFORMANCE Completed Portfolio Transformation Revenue Volume Growth Built out Biotechnology Capability EBITDA Margin Expansion Expanded our Global Footprint EPS Growth Developed New Technologies Continued Strong Cash Flow Business Developm
Slide 6: A Well Balanced, Diversified Global Business
A Well Balanced, Diversified Global Business Geography End Use Customer Channel Technology Market Type Americas 55% Food 66% Meat 22% Global 31% Retail 68% Integrated Taste Technology Technologies 81% Applications APMEA 24% Beverage 27% Snacks 11% Regional 34% Foodservice 32% Biotechnology Savoury 3
Slide 7: Kerry's Differentiated Capability
Kerry’s Differentiated Capability 1. Extensive Integrated 2. Holistic Food & Beverage Application Expertise 3. Integrated Solutions Leadership Technology Capabilities Layering Technology Customised Solutions Dedicated Channel-Specific Teams Food & Beverage Focus Solving multi-dimensional challenges
Slide 8: Today's Potential
Today’s Potential Dynamic Market €100bn Market Market Landscape Shifts Driving Opportunity: • Health & Wellness Focus ~€87bn RENOVATION • Regulatory Developments Today’s Total • GLP-1 Addressable Market • Taste Optimisation • Nutritional Optimisation • Today’s Digital Consumer • Clean Label • Consum
Slide 9: Today's Breakout Sessions
Today’s Breakout Sessions Accelerating Renovation for Next Generation Kerry’s Digital Innovation Dynamic Market Taste Foodservice Transformation Through Needs Tailwind Enabling Biotechnology Business & Financial Delivery
Slide 10: Accelerating Innovation through Biotechnology
ACCELERATING INNOVATION through Biotechnology Modulation for Future Nutrition Biochemistry for Tomorrow’s Scarcity Fermentation Reimagining Natural
Slide 11: Renovation for a Dynamic Market
Renovation for a DYNAMIC MARKET
Slide 12: Pioneering Next Gen Taste
Pioneering NEXT GEN TASTE Authentic Stocks, Kerry Xperience™ Kerry Food and Beverage Systems TASTE PORTFOLIO Colors Tastesense™ Fat Coffee Tastesense™ Extracts Masking Citrus Tastesense™ Extracts Sweetness Cocoa Tastesense’ Extracts Salt
Slide 13: Kerry's Foodservice Tailwind
Kerry’s FOODSERVICE TAILWIND
Slide 14: Enabling Business & Financial Delivery
Digital Transformation ENABLING BUSINESS & FINANCIAL DELIVERY
Slide 15: Dr. Albert McQuaid, Chief Science & Technology Officer
IKKERRY Solving for a Complex World DR. ALBERT MCQUAID Chief Science & Technology Officer
Slide 16: Leading Research, Development and Applications Capabilities
Leading Research, Development and Applications Capabilities 1,300+ Scientists 1 5-6% 60+ Target Revenue Invested in RD&A €315m Technology and In 2025 Innovation Centres 22 Globally Core technologies DIGITAL INVESTMENT 1,200 Discovery 33 Patents and patents End use applications Formulation markets ~4
Slide 17: Broad and Deep Technology Portfolio
Broad and Deep Technology Portfolio Bio-fermentation & Bio-transformation
Slide 18: Market Winning Innovations
Market Winning Innovations Industry Leading Best in Class Most Next New to Sodium Sugar Advanced Generation World Reduction Reduction Masking Clean Label Fermentation Portfolio Solutions Portfolio Preservation Taste Solutions Combining Lactase Tastesense Salt For nutrient dense foods For Bakery & Me
Slide 19: Accelerating Innovation Through Biotechnology
Accelerating Innovation Through Biotechnology 1 2 3 4 5 MODULATION FERMENTATION BIOCHEMISTRY FUTURE PROOF FOOD AS A FOR ADVANCED REIMAGINING FOR TOMORROW’S PRESERVATION THERAPEUTIC NUTRITION NATURAL SCARCITY €50m+ €50m+ €50m+ €50m+ €50m+
Slide 20: Today's Breakout Session
Today’s Breakout Session 1 MODULATION FOR ADVANCED NUTRITION 2 FERMENTATION REIMAGINING NATURAL 3 BIOCHEMISTRY FOR TOMORROW’S SCARCITY Meeting Future Sorbate-free Preservation Coffee and Cocoa Nutrition Challenges for Beverages Solving raw material challenges through Modulation • Salt Bio-fermented
Slide 21: John Cahalane, President & CEO Kerry North America
IKKERRY Solving for a Complex World JOHN CAHALANE President & CEO | Kerry North America
Slide 22: Our Business in North America
Our Business in North America Business PROFILE The Changing LANDSCAPE Opportunity FOR KERRY
Slide 23: Business Profile
Our Business in North America Business Profile Largest Region for Kerry Strong Presence Strong Track Record in North America ~3% ~5,500 employees Volume CAGR €3.0bn €1.1bn 45 Manufacturing locations €3.0bn North America Europe, APMEA, LATAM North America 2008 2025 business
Slide 24: The Changing Landscape
Our Business in North America The Changing Landscape END USE CUSTOMER CHANNEL MARKET TYPE Food Global Foodservice Beverage Local and Regional Retail • Large and Mid-size Brands • Large and Mid-size Brands Pharma & Other • Emerging Brands • Emerging Brands • Retailer Brands • Retailer Brands • Foodse
Slide 25: Opportunity for Kerry
Our Business in North America Opportunity for Kerry CHANGE CREATES OPPORTUNITY COMPLEXITY DRIVES PARTNERSHIP SOLUTIONS AT SPEED WIN
Slide 26: Marguerite Larkin, Chief Financial Officer
IKKERRY Solving for a Complex World MARGUERITE LARKIN Chief Financial Officer
Slide 27: Key Messages
Key Messages 1. Strong Track Record 2. Growth-Led, Balanced Model 3. Strategic Capital Allocation
Slide 28: Strong Track Record (2022-2025)
Strong Track Record (2022-2025) GROWTH RETURNS SUSTAINABILITY Average Volume Growth1 Average Cash Carbon Reduction4 >300bps market Conversion % On track to achieve +3.8% outperformance 88% 52% 55% reduction by 2030 Good cash generation ahead of 80% target EBITDA Margin 2 Food Waste Reduction4 +320bp
Slide 29: Our Financial Targets (2027-2030)
Our Financial Targets (2027-2030) GROWTH Volume Growth1 3-5% EBITDA Margin2 20-21% CCY Adjusted EPS Growth HSD+ RETURNS Cash Conversion 85%+ ROACE3 12-13% 1Based on assumption of flat end market growth | 2By 2030 and assumes neutral currency and input costs | 3By 2030 | CCY = Constant Currency | HSD
Slide 30: Volume Growth
Volume Growth Our History Volume Growth Target Range Assumptions Key Growth Drivers (2022-25) (Target Range 3-5% growth) 3.8% • Continued end market Foodservice MSD+ outperformance of 300bps+ Emerging Markets HSD • Assumes flat end market growth rate Renovation ~40% PIPELINE • Addressable market gro
Slide 31: EBITDA Margin Expansion
EBITDA Margin Expansion 20-21% Key drivers: 19-20% • Operating leverage 17.9% • Portfolio mix • Efficiencies Continued investments 2025 Efficiencies – Operating leverage 2028 EBITDA 2030 EBITDA Accelerate 2.0 & portfolio mix margin target margin target 2025 Gross Margin of 38% → Moving to 39%+ by 20
Slide 32: Key Drivers of Margin Expansion
Key Drivers of Margin Expansion EFFICIENCIES OPERATING LEVERAGE PORTFOLIO MIX Accelerate 2.0 → Volume Led Revenue Growth → Multi-layered Technology Solutions → Footprint Optimisation → Biotechnology Solutions → Digital Excellence
Slide 33: Cash and Returns
Cash and Returns Continued Strong Free Cash 85%+ Further Progression Flow Conversion New Cash on Return on Average 12-13% Conversion Capital Employed By 2030 Target €2.8bn Free Cash Flow €3.5bn 10.6% 88% Cash Conversion 10.6% Free Cash Flow 10.3% (2022-2025) (2027-2030) 10.0% €766m €701m €640m €643m
Slide 34: Capital Allocation Priority Framework
Capital Allocation Priority Framework REINVESTMENT CAPITAL RETURNS 1 Capital Investment 4-5% of revenue 2 Dividends Double-digit growth 3 M&A Disciplined strategic approach 4 Share Buybacks Evaluate ongoing based on market conditions and strategic alternatives Supported by a strong financial positio
Slide 35: Appendix
Appendix
Slide 36: Financial Metric Definitions
Financial Metric Definitions Volume Growth Free Cash Flow This represents the sales performance period-on-period, Free cash flow is EBITDA plus the movement in working capital, excluding pass-through pricing on input costs, currency impacts, capital expenditure net (purchase of assets, payment of le
Slide 37: Kerry Investor Day 8 October 2026
Kerry Investor Day 8 October 2026